<DOC>
	<DOCNO>NCT00931398</DOCNO>
	<brief_summary>The purpose propose study determine effectiveness methylphenidate HCl ( Concerta ) college student ADHD . This study consist 110 college student age 18 25 enrol full-time local junior college . The study consist 8-week double-blind , placebo-controlled trial placebo versus methylphenidate HCl ( Concerta® ) follow 10-week extension open label methylphenidate HCl ( Concerta® ) .</brief_summary>
	<brief_title>Treatment College Students With Attention-Deficit/Hyperactivity Disorder ( ADHD ) Using OROS Methylphenidate</brief_title>
	<detailed_description>There trial drug efficacy safety treatment perform specifically college student Attention-Deficit/Hyperactivity Disorder ( ADHD ) . Although data base adult population often extrapolate generalized college population , unique treatment demand college student ADHD represent day-to-day functioning adult ADHD . For example , although adult may able choose employment capitalizes skill set tolerate ADHD-related deficit , college student must manage intensive learn experience environment place unparalleled demand higher order cognitive process deficient ADHD . In addition , may important address comorbidities may common among ADHD college student . This could range eat disorder , depression anxiety alcoholism drug abuse . For example , heavy drinking peak college student year regardless ADHD long-term course underlying predisposition may different among individual history ADHD ( Molina et al. , 2007 ) . Although case study , limited study ADHD comorbidities college student perhaps may challenge recruit respectable sample size . Furthermore , may important recognize college student never develop diagnosable ADHD symptom child , sign may manifest harmful way college demand academic rigor organization reach height . Given juxtapose condition academic demand , autonomy parent , increased opportunity drug abuse , become imperative directly address treatment population . Much research leave perform unique population ADHD patient .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Ages 1825 year , inclusive DSMIV diagnosis ADHD ( subtype ) Clinical Global Impressions scale ( CGI ) —Severity score ≥4 ( `` Moderately ill '' high ) ADHD Pregnancy history seizure disorder , neurological medical disorder medication treatment may present considerable risk Abnormal liver function History pervasive developmental disorder , schizophrenia , psychotic disorder , eat disorder Currently take psychotropic medication discontinuation would present significant risk ( allow subject satisfactory medication response discontinue medication participate ) Active substance dependence lack control substance use allow safe medication administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>